Organigram Global (STU:0OG) Beta: 0.8159 (As of Jun. 26, 2026)


STU:0OG Organigram Global Inc STU:0OG
60 GF Score
Price €0.82
GF Value €1.46
Valuation Possible Value Trap
! 1 Warning Sign
View Full Analysis

What is Organigram Global Beta?

Organigram Global STU:0OG -0.85% 60 Beta is 0.8159 as of Jun. 26, 2026. GuruFocus rates STU:0OG with a GF Score™ of 60/100 and a GF Value™ of €1.46 (Possible Value Trap). The stock has 1 warning sign investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-26), Organigram Global's Beta is 0.8159.


Organigram Global  (STU:0OG) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Organigram Global Beta Related Terms


Organigram Global Beta Historical Data

* Premium members only.

The historical data trend for Organigram Global's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Organigram Global Beta Chart

Organigram Global Annual Data
Trend Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Sep24 Sep25
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.19 1.11 0.66 1.95 2.14

Organigram Global Quarterly Data
Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.95 1.84 2.14 0.96 1.32

STU:0OG vs ZTS: Beta Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Organigram Global's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Organigram Global Beta vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Organigram Global's Beta distribution charts can be found below:

* The bar in red indicates where Organigram Global's Beta falls into.


STU:0OG
60GF Score
Organigram Global Inc STU:0OG
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Organigram Global Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 0.8159 mean?
Organigram Global (STU:0OG) has a Beta of 0.8159 as of Jun. 26, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Organigram Global and its competitors.
Is Organigram Global's Beta too high?
Organigram Global's current Beta is 0.8159. Overall, Organigram Global has a GF Score™ of 60/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Organigram Global's Beta compare to ZTS?
Organigram Global's Beta of 0.8159 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Drug Manufacturers company?
A good Beta depends on the Drug Manufacturers industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Organigram Global and its competitors. Organigram Global's current Beta is 0.8159. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Organigram Global stock overvalued right now?
Based on GuruFocus' analysis, Organigram Global (STU:0OG) is currently considered Possible Value Trap. The stock's GF Value™ is €1.46, compared to a current price of €0.82 — trading 44.1% below its estimated fair value. The current Beta is 0.8159. Organigram Global's overall GF Score™ is 60/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Organigram Global (STU:0OG), the current Beta is 0.8159 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Organigram Global (STU:0OG) Overvalued in 2026?

Based on GuruFocus' analysis, Organigram Global stock appears to be undervalued. The current stock price of €0.82 is trading 44.1% below its estimated GF Value™ of €1.46. GuruFocus considers Organigram Global to be Possible Value Trap.

Key valuation signals for STU:0OG:

  • Beta: 0.8159
  • GF Value™: €1.46 vs. price of €0.82 (44.1% below fair value)
  • GF Score™: 60/100 with 1 warning sign

No single metric tells the full story. See the STU:0OG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Organigram Global Business Description

Other Exchanges OGI:USAOGI:Canada
Address 145 King Street West, Suite 1400, Toronto, ON, CAN, M5H 1J8
Organigram Global Inc is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. It is is focused on producing high-quality cannabis for adult recreational consumers. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba.
60GF Score

Get the complete analysis for STU:0OG

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.82
Price
€1.46
GF Value